Novavax NVAX
NASDAQ NVAX
$10.81 -0.01 (-0.09%)
At close: Sep 30, 2026 · 4:00 PM EDT

Novavax (NVAX) Accounts Payables (2010 - 2026)

Updated

Novavax's Accounts Payables came in at $22.94 million for Q2 2026, down 54.7% from $50.6 million a year earlier but up 42.5% from the prior quarter.

Analysis

Novavax (NVAX) Accounts Payables (2010 - 2026) Analysis & Trends

At the end of FY2025, Novavax's Accounts Payables was $24.58 million, down 40.9% from FY2024.

  • Accounts Payables has declined in each of the last three years, with a five-year compound annual growth rate of -14.7% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $41.58 million in FY2024 (-68.6%), $132.61 million in FY2023 (-38.8%), $216.52 million in FY2022 (+70.4%) and $127.05 million in FY2021 (+133.8%).
  • The five-year range for quarterly Accounts Payables is $15.23 million (Q3 2025) to $386.49 million (Q2 2022).
  • Year-over-year, Accounts Payables has declined for 14 consecutive quarters, with an average decline of 51.5% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in Q2 2022 (growth of 422.3%), and the weakest in Q2 2023 (a decline of 77.4%).
  • Business Quant data shows NVAX's Accounts Payables at $16.1 million (Q1 2026), $24.58 million (Q4 2025) and $15.23 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Novavax 1.78 Bn -1.23 Bn 42.45 Mn 22.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.94 Mn
Mar 31, 2026 16.10 Mn
Dec 31, 2025 24.58 Mn
Sep 30, 2025 15.23 Mn
Jun 30, 2025 50.60 Mn
Mar 31, 2025 34.16 Mn
Dec 31, 2024 41.58 Mn
Sep 30, 2024 57.52 Mn
Jun 30, 2024 79.96 Mn
Mar 31, 2024 57.72 Mn
Dec 31, 2023 132.61 Mn
Sep 30, 2023 101.91 Mn
Jun 30, 2023 87.25 Mn
Mar 31, 2023 124.80 Mn
Dec 31, 2022 216.52 Mn
Sep 30, 2022 145.00 Mn
Jun 30, 2022 386.49 Mn
Mar 31, 2022 135.13 Mn
Dec 31, 2021 127.05 Mn
Sep 30, 2021 59.56 Mn
API Access

Novavax Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=NVAX&period=max&api_key=YOUR_API_KEY